|
Status |
Public on Dec 31, 2011 |
Title |
270_81 |
Sample type |
RNA |
|
|
Source name |
Uveal melanoma
|
Organism |
Homo sapiens |
Characteristics |
cell line: GNAQ mutant treatment: post treatment
|
Treatment protocol |
Untreated versus 8h Selumetinib
|
Growth protocol |
RPMI 10% FBS
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted from cells using Trizol lysis reagent
|
Label |
Biotin
|
Label protocol |
Per manufacturer's instructions
|
|
|
Hybridization protocol |
Per manufacturer's instructions
|
Scan protocol |
scanned on the BeadArray Reader, iScan system.
|
Data processing |
Signal intensity generated with Illumina iScan Control software and expression was quantile normalized using the preprocessCore library in R (R 2.10.1, preprocessCore version 1.8.0).
|
|
|
Submission date |
Nov 13, 2011 |
Last update date |
May 17, 2012 |
Contact name |
Brian Denton |
E-mail(s) |
[email protected]
|
Organization name |
Memorial Sloan-Kettering Cancer Center
|
Department |
Epidemiology and Biostatistics
|
Street address |
307 E. 63rd Street
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platform ID |
GPL10558 |
Series (1) |
GSE33655 |
Whole-transcript expression data for uveal melanoma |
|